
AXIIF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for AXIIF and 80,000+ other tickers.
See exactly how AXIIF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for AXIIF and 80,000+ other tickers.
Alexium International Group Ltd. engages in the provision of developing chemical solutions. It is involved in the development and licensing of its proprietary flame retardant phase change material, chemicals and reactive surface treatment technologies. Its products include Alexicool PCM, Biocool PCM, Eclipsys, Delcool, Alexiflam Solutions and Alexishield. The company was founded on May 30, 1994 and is headquartered in Greer, SC.

Alexium International Group Limited (AXIIF) Discusses Microtek Acquisition, Business Progress and Capital Raising Transcript

Alexium International Group Limited (AXIIF) Discusses First Half Results, Microtek Acquisition, and Outlook for Business Recovery Prepared Remarks Transcript

Alexium International Group Limited (AXIIF) Discusses Acquisition of Microencapsulation and PCM Businesses of Microtek and Associated Entitlement Offer Transcript

Alexium International Group Limited (OTCPK:AXIIF) Shareholder/Analyst Call November 20, 2025 6:00 PM EST Company Participants Simon Moore James Williamson William Blackburn - CEO, MD & Director Lisa Hubka - Vice President of Finance Presentation Simon Moore Good morning, ladies and gentlemen. Welcome to the 2025 Annual General Meeting of Shareholders of Alexium International Group Limited.

Alexium International Group Limited (OTCPK:AXIIF) Q4 2025 Earnings Call October 15, 2025 6:00 PM EDT Company Participants Simon Moore William Blackburn - CEO, MD & Director Lisa Hubka - Vice President of Finance Presentation Simon Moore Good morning, and welcome to the Investor Update Webinar for Alexium International Group Limited. My name is Simon Moore, and I'm the Interim Chair of Alexium International Group Limited.